Stocktoria

Fortrea Holdings Inc. FTRE

Nasdaq · stock · Services-Medical Laboratories · website · IPO 2023-06-16 · LEI

Fortrea Holdings Inc. financials (annual)

Revenue
$2.84B $2.84B $2.70B $2.72B 2022202320242025
Net income
$186.2M -$25.2M -$328.5M -$986.2M 2022202320242025
Free cash flow
2022202320242025

Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022
Revenue$2.7B$2.7B$2.8B$2.8B
SG&A expense$456.4M$560.7M$448.1M$416.1M
Operating income-$872.6M-$161.9M$32.0M$187.1M
Interest expense$69.8M$200,000
Income tax$3.2M-$3.5M$1.2M$41.1M
Net income-$986.2M-$328.5M-$25.2M$186.2M
EPS (diluted)$-10.81$-3.67$-0.29$2.09
Operating cash flow$113.5M$262.8M$168.4M$82.7M
Cash & equivalents$174.6M$118.5M$108.6M$112.0M
Total assets$2.7B$3.6B$4.3B$4.3B
Total liabilities$2.2B$2.2B$2.6B$945.3M
Shareholders' equity$563.5M$1.4B$1.7B$3.3B

Growth · year-over-year · Revenue CAGR -1.4%

MetricFY2025FY2024FY2023FY2022
Revenue growth+1.0%-5.1%+0.2%
Net income growth-113.5%
EPS growth-113.9%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.